22.05.2022 Views

DƯỢC LÍ Goodman & Gilman's The Pharmacological Basis of Therapeutics 12th, 2010

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Table 11–3

Dosing Ranges for Neuromuscular Blocking Agents

MAINTENANCE DOSE

CONTINUOUS

INITIATION INTERMITTENT INFUSION

AGENT DOSE (mg/kg) INJECTION (mg/kg) (μg/kg/min)

Succinylcholine 0.5-1 0.04-0.07 N/A

D-Tubocurarine a 0.6 0.25-0.5 2-3

Metocurine a 0.4 0.5-1 N/A

Atracurium 0.5 0.08-0.1 5-10

Cisatracurium 0.1-0.4 0.03 1-3

Mivacurium 0.15-0.25 0.1 9-10

Doxacurium a 0.03-0.06 0.005-0.01 N/A

Pancuronium 0.08-0.1 0.01-0.015 1

Rocuronium 0.6-1.2 0.1-0.2 10-12

Vecuronium 0.1 0.01-0.015 0.8-1

Gantacurium a 0.2-0.5 N/A N/A

a

Not commercially available in the U.S.

moiety by plasma esterases and by a spontaneous or Hofmann degradation

(cleavage of the N-alkyl portion in the benzylisoquinoline).

Hence two routes for degradation are available, both of which remain

functional in renal failure. Mivacurium is extremely sensitive to

catalysis by cholinesterase or other plasma hydrolases, accounting

for its short duration of action.

Side effects are not yet fully characterized for gantacurium,

but transient adverse cardiovascular effects suggestive of histamine

release have been observed at doses over three times the ED 95

.

Clinical Uses

Muscle Relaxation. The main clinical use of the neuromuscular

blocking agents is as an adjuvant in surgical

anesthesia to obtain relaxation of skeletal muscle, particularly

of the abdominal wall, to facilitate operative

manipulations. With muscle relaxation no longer

dependent on the depth of general anesthesia, a much

lighter level of anesthesia suffices. Thus, the risk of respiratory

and cardiovascular depression is minimized,

and post-anesthetic recovery is shortened. These considerations

notwithstanding, neuromuscular blocking

agents cannot be used to substitute for inadequate depth

of anesthesia. Otherwise, a risk of reflex responses to

painful stimuli and conscious recall may occur.

Muscle relaxation is also of value in various

orthopedic procedures, such as the correction of dislocations

and the alignment of fractures.

Neuromuscular blocking agents of short duration often

are used to facilitate endotracheal intubation and have

been used to facilitate laryngoscopy, bronchoscopy, and

esophagoscopy in combination with a general anesthetic

agent.

Neuromuscular blocking agents are administered

parenterally, nearly always intravenously. As potentially

hazardous drugs, they should be administered to

patients only by anesthesiologists and other clinicians

who have had extensive training in their use and in a

setting where facilities for respiratory and cardiovascular

resuscitation are immediately at hand. Detailed

information on dosage and monitoring the extent of

muscle relaxation can be found in anesthesiology textbooks

(Naguib and Lien, 2005; Pollard, 1994).

Measurement of Neuromuscular Blockade in Humans. Assessment of

neuromuscular block usually is performed by stimulation of the ulnar

nerve. Responses are monitored from compound action potentials or

muscle tension developed in the adductor pollicis (thumb) muscle.

Responses to repetitive or tetanic stimuli are most useful for evaluation

of blockade of transmission because individual measurements of twitch

tension must be related to control values obtained prior to the administration

of drugs. Thus, stimulus schedules such as the “train of four”

and the “double burst” or responses to tetanic stimulation are preferred

procedures (Drenck et al., 1989; Waud and Waud, 1972). Rates of

onset of blockade and recovery are more rapid in the airway musculature

(jaw, larynx, and diaphragm) than in the thumb. Hence, tracheal

intubation can be performed before onset of complete block at the

adductor pollicis, whereas partial recovery of function of this muscle

allows sufficient recovery of respiration for extubation (Naguib and

Lien, 2005). Differences in rates of onset of blockade, recovery from

blockade, and intrinsic sensitivity between the stimulated muscle and

those of the larynx, abdomen, and diaphragm should be considered.

265

CHAPTER 11

AGENTS ACTING AT THE NEUROMUSCULAR JUNCTION AND AUTONOMIC GANGLIA

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!